.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
McKinsey
Argus Health
Farmers Insurance
Fuji
Cantor Fitzgerald
Dow
Colorcon
McKesson
Healthtrust

Generated: January 23, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: aripiprazole lauroxil

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Alkermes IncARISTADAaripiprazole lauroxilSUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR207533NDAAlkermes, Inc.65757-401-031 SYRINGE in 1 CARTON (65757-401-03) > 1.6 mL in 1 SYRINGE (65757-401-01)
Alkermes IncARISTADAaripiprazole lauroxilSUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR207533NDAAlkermes, Inc.65757-402-031 SYRINGE in 1 CARTON (65757-402-03) > 2.4 mL in 1 SYRINGE (65757-402-01)
Alkermes IncARISTADAaripiprazole lauroxilSUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR207533NDAAlkermes, Inc.65757-403-031 SYRINGE in 1 CARTON (65757-403-03) > 3.2 mL in 1 SYRINGE (65757-403-01)
Alkermes IncARISTADAaripiprazole lauroxilSUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR207533NDAAlkermes, Inc.65757-404-031 SYRINGE in 1 CARTON (65757-404-03) > 3.9 mL in 1 SYRINGE (65757-404-01)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Dow
Federal Trade Commission
Queensland Health
Teva
Express Scripts
US Army
Mallinckrodt
Novartis
US Department of Justice

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot